Haemangioma of skin and drugs of ingredients of teriflunomide - a phase IV clinical study of FDA data


Haemangioma of skin is found among people who take drugs with ingredients of teriflunomide, especially for people who are female, 40-49 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 48,010 people who have side effects when taking drugs with ingredients of teriflunomide from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Aubagio, Teriflunomide.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 22, 2023

48,010 people reported to have side effects when taking drugs with ingredients of teriflunomide.
Among them, 6 people (0.01%) have Haemangioma of skin

What is Haemangioma of skin?

Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs) is found to be associated with 532 drugs and 277 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of teriflunomide cause Haemangioma of skin?

Time on drugs with ingredients of teriflunomide when people have Haemangioma of skin *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Haemangioma of skin when taking drugs with ingredients of teriflunomide *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Haemangioma of skin when taking drugs with ingredients of teriflunomide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Conditions people have *:

  1. Pain: 2 people, 33.33%
  2. Tooth Abscess (pus formation in tooth): 1 person, 16.67%
  3. Productive Cough: 1 person, 16.67%
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 16.67%
  5. Breathing Difficulty: 1 person, 16.67%

Other drugs people take *:

  1. Gilenya: 6 people, 100.00%
  2. Duoneb: 1 person, 16.67%
  3. Augmentin: 1 person, 16.67%

Other side effects people have besides Haemangioma of skin *:

  1. White Blood Cell Count Decreased: 6 people, 100.00%
  2. Pain: 6 people, 100.00%
  3. Constipation: 6 people, 100.00%
  4. Depression: 6 people, 100.00%
  5. Dysmenorrhea (painful menstruation): 6 people, 100.00%
  6. Hair Loss: 6 people, 100.00%
  7. Headache (pain in head): 6 people, 100.00%
  8. Itching: 6 people, 100.00%
  9. Joint Swelling: 6 people, 100.00%
  10. Lymphopenia (an abnormally low level of lymphocytes in the blood): 6 people, 100.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of teriflunomide, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on teriflunomide. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: